articleOphthalmologyOct 1, 2006Closed access

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

RLRobert L. AveryJPJoel PearlmanDJDante J. PieramiciMRMelvin RabenaACAlessandro Castellarin

California Retina Consultants

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

798
total citations
FWCI
64.82
Percentile
100%
References
24
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Medicine
  • Bevacizumab
  • Diabetic retinopathy
  • Ophthalmology
  • Retinopathy
  • Proliferative vitreoretinopathy
  • Diabetes mellitus
  • Chemotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.